Your browser doesn't support javascript.
loading
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-ßRI inhibitor galunisertib.
Giannelli, Gianluigi; Santoro, Armando; Kelley, Robin K; Gane, Ed; Paradis, Valerie; Cleverly, Ann; Smith, Claire; Estrem, Shawn T; Man, Michael; Wang, Shuaicheng; Lahn, Michael M; Raymond, Eric; Benhadji, Karim A; Faivre, Sandrine.
Afiliação
  • Giannelli G; National Institute of Gastroenterology, "s. De Bellis" Research Hospital, Castellana Grotte, Bari, Italy.
  • Santoro A; Humanitas Clinical Institute, Milano, Italy.
  • Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, United States of America.
  • Gane E; Auckland City Hospital, Auckland, New Zealand.
  • Paradis V; Beaujon Hospital, Clichy, France.
  • Cleverly A; Eli Lilly and Company, Windlesham, Surrey, United Kingdom.
  • Smith C; Eli Lilly and Company, Windlesham, Surrey, United Kingdom.
  • Estrem ST; Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Man M; Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Wang S; BioStat Solutions, Inc., Frederick, Maryland, United States of America.
  • Lahn MM; Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Raymond E; Paris Saint-Joseph Hospital Center, Paris, France.
  • Benhadji KA; Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Faivre S; Paris Saint-Joseph Hospital Center, Paris, France.
PLoS One ; 15(3): e0222259, 2020.
Article em En | MEDLINE | ID: mdl-32210440

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pirazóis / Quinolinas / Carcinoma Hepatocelular / Receptor do Fator de Crescimento Transformador beta Tipo I / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pirazóis / Quinolinas / Carcinoma Hepatocelular / Receptor do Fator de Crescimento Transformador beta Tipo I / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Ano de publicação: 2020 Tipo de documento: Article